SW Yancey
- Late-breaking abstract: Oral corticosteroid-sparing effect of mepolizumab in severe eosinophilic asthma: The SIRIUS studyBy EH Bel, SE Wenzel, PJ Thompson, CM Prazma, O Keene, SW Yancey, H Ortega and ID PavordEH Bel1Pulmonology, Academic Medical Centre, Amsterdam, NetherlandsSE Wenzel2University of Pittsburgh Asthma Institute at UPMC, Montefiore Hospital, Pittsburgh, PA,PJ Thompson3Centre for Asthma, Allergy and Respiratory Research, University of Western Australia, Crawley, WA, AustraliaCM Prazma4Respiratory Therapeutic Area, GlaxoSmithKline, Research Triangle Park, NC,O Keene5Clinical Statistics, GlaxoSmithKline, Stockley Park, Middlesex, United KingdomSW Yancey4Respiratory Therapeutic Area, GlaxoSmithKline, Research Triangle Park, NC,H Ortega4Respiratory Therapeutic Area, GlaxoSmithKline, Research Triangle Park, NC,ID Pavord6Respiratory Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.